| Dr Armand B Cognetta Jr, MD | |
|
1707 Riggins Rd, Tallahassee, FL 32308-5317 | |
| (850) 877-4134 | |
| (850) 402-9130 |
| Full Name | Dr Armand B Cognetta Jr |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 45 Years |
| Location | 1707 Riggins Rd, Tallahassee, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003922592 | NPI | - | NPPES |
| 37419 | Other | FL | BLUE CROSS BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ND0101X | Dermatology - Mohs-micrographic Surgery | ME0036591 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dermatology Associates Of Tallahassee Pa | 6608775499 | 42 |
News Archive
In the emerging biosimilar market, biosimilar antibodies are being developed to treat conditions currently addressed by their original, targeted biological therapy. Only a few biosimilars are approved by the EMA, and just one has been approved by the FDA. In a review article, researchers used the clinical development data from one drug to explore the broader benefits and risks of these cost-effective, but as yet unfamiliar treatment options.
Dartmouth College researchers are going to market with the first-ever sensor that detects secondhand and thirdhand tobacco and marijuana smoke in real time.
Avaxia Biologics, Inc., a privately-held biotech company using its proprietary platform technology to develop orally-active antibody therapeutics for the treatment of gastrointestinal diseases, is proud to announce that it has received a second round of funding from the National Institutes of Health for its work in inflammatory bowel disease.
New data released demonstrates that the addition of Zometa (zoledronic acid) injection to standard chemotherapy before breast cancer surgery reduces the size of breast tumors more effectively than chemotherapy alone in women with early-stage disease.
Experiencing multiple stressors triggered by the COVID-19 pandemic – such as unemployment – and COVID-19-related media consumption are directly linked to rising acute stress and depressive symptoms across the U.S., according to a groundbreaking University of California, Irvine study.
› Verified 3 days ago
| Entity Name | Dermatology Associates Of Tallahassee Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295842672 PECOS PAC ID: 6608775499 Enrollment ID: O20031231000062 |
News Archive
In the emerging biosimilar market, biosimilar antibodies are being developed to treat conditions currently addressed by their original, targeted biological therapy. Only a few biosimilars are approved by the EMA, and just one has been approved by the FDA. In a review article, researchers used the clinical development data from one drug to explore the broader benefits and risks of these cost-effective, but as yet unfamiliar treatment options.
Dartmouth College researchers are going to market with the first-ever sensor that detects secondhand and thirdhand tobacco and marijuana smoke in real time.
Avaxia Biologics, Inc., a privately-held biotech company using its proprietary platform technology to develop orally-active antibody therapeutics for the treatment of gastrointestinal diseases, is proud to announce that it has received a second round of funding from the National Institutes of Health for its work in inflammatory bowel disease.
New data released demonstrates that the addition of Zometa (zoledronic acid) injection to standard chemotherapy before breast cancer surgery reduces the size of breast tumors more effectively than chemotherapy alone in women with early-stage disease.
Experiencing multiple stressors triggered by the COVID-19 pandemic – such as unemployment – and COVID-19-related media consumption are directly linked to rising acute stress and depressive symptoms across the U.S., according to a groundbreaking University of California, Irvine study.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Armand B Cognetta Jr, MD Po Box 13859, Tallahassee, FL 32317-3859 Ph: (850) 877-4134 | Dr Armand B Cognetta Jr, MD 1707 Riggins Rd, Tallahassee, FL 32308-5317 Ph: (850) 877-4134 |
News Archive
In the emerging biosimilar market, biosimilar antibodies are being developed to treat conditions currently addressed by their original, targeted biological therapy. Only a few biosimilars are approved by the EMA, and just one has been approved by the FDA. In a review article, researchers used the clinical development data from one drug to explore the broader benefits and risks of these cost-effective, but as yet unfamiliar treatment options.
Dartmouth College researchers are going to market with the first-ever sensor that detects secondhand and thirdhand tobacco and marijuana smoke in real time.
Avaxia Biologics, Inc., a privately-held biotech company using its proprietary platform technology to develop orally-active antibody therapeutics for the treatment of gastrointestinal diseases, is proud to announce that it has received a second round of funding from the National Institutes of Health for its work in inflammatory bowel disease.
New data released demonstrates that the addition of Zometa (zoledronic acid) injection to standard chemotherapy before breast cancer surgery reduces the size of breast tumors more effectively than chemotherapy alone in women with early-stage disease.
Experiencing multiple stressors triggered by the COVID-19 pandemic – such as unemployment – and COVID-19-related media consumption are directly linked to rising acute stress and depressive symptoms across the U.S., according to a groundbreaking University of California, Irvine study.
› Verified 3 days ago
David Pascoe, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1981 Capital Cir Ne, Tallahassee, FL 32308 Phone: 850-402-9444 Fax: 850-402-0188 | |
Dr. William Harris Green, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1707 Riggins Rd, Tallahassee, FL 32308 Phone: 850-877-4134 Fax: 850-402-9130 | |
Pamela Schofield Kennedy, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1355 Thomaswood Dr, Tallahassee, FL 32308 Phone: 850-656-4555 Fax: 850-656-4557 | |
Emily Jacox, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 2626 Capital Medical Blvd, Tallahassee, FL 32308 Phone: 850-325-5000 | |
Dr. Oen-hiang Cynthia Tie, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1981 Capital Cir Ne, Tallahassee, FL 32308 Phone: 850-402-9444 Fax: 850-402-0188 | |
Michael Jay Bernhardt, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1626 Riggins Rd, Tallahassee, FL 32308 Phone: 850-877-4134 Fax: 850-402-9130 |